膣スリング - 世界市場の考察、競合情勢、市場予測（2030年）

世界の膣スリングの市場規模は12億1,799万米ドルに達し、2030年までに16億252万米ドルとなり、2024年～2030年の予測期間にCAGRで4.73％の成長が推定されます。市場は、女性の尿失禁症例の有病率の上昇、ストレス性尿失禁や骨盤底の弱体化を引き起こしやすい老年人口の増加、革新的な膣スリングの開発の急増、妊娠、糖尿病、更年期などの条件によって引き起こされる身体的問題の増加などの要因により、大きな市場成長を示しています。さらに、製品の発売と承認の増加、市場における主要企業のプレゼンスなどが、市場における膣スリングへのニーズを生み出します。最後に、医療支出の増加は、膣スリングの需要に確実に影響します。したがって、市場は2024年～2030年の予測期間に大幅なCAGRで成長すると推定されます。

膣スリングの市場力学

主に女性を中心とした尿失禁の有病率の上昇が、膣スリング市場を牽引しています。例えば、National Association for Continence（2019）によると、アメリカでは最大4,000万人の女性が人生のある時点で膀胱漏れの問題を経験しています。2019年の同調査によると、新たに母親となった女性のほぼ半数が正常分娩後に失禁を経験し、帝王切開後には約6人に1人が失禁を経験しています。

さらに、2019年にAmerican Academy of Family Physiciansが言及した研究によると、尿失禁（UI）は一般的な問題であり、米国の成人女性の有病率は51％です。

さらに、2022年にContinence Foundation of Australiaが提供したデータによると、同年には500万人以上のオーストラリア人（15歳以上の4人に1人）が膀胱や腸のコントロール障害を経験しており、尿失禁患者の80％は女性です。世界のその他の地域でも同様の動向が見られると可能性が高いです。また、ストレス性尿失禁は41歳～55歳以上の女性に多いことが確認されています。

さらに、ストレス性尿失禁を起こしやすく、骨盤底が弱くなりやすい老年人口の急増が、膣スリング市場の大きな促進要因になると予測されます。例えば、国連のレポート「World Population Ageing 2020 Highlights」によると、2020年に世界全体で65歳以上の高齢者が約7億2,700万人になります。また、同資料によれば、今後30年間で、世界の高齢者数は2倍以上に増加し、2050年までに約15億人に達すると予測されています。

さらに、United States Census Bureau 2022によると、2023年までに米国に住む65歳以上の成人は5,400万人を超え、米国人口の約16.5％を占めます。資料によると、米国に住む高齢者の数は多く、増加傾向にあります。2050年までに65歳以上の成人の総数は推定8,570万人に増加し、米国全体の人口の約20％を占めると予測されています。

したがって、老年人口の増加は、主にストレス性尿失禁などの尿失禁の発症につながり、それによって膣スリングシステムなどのストレス性尿失禁機器を使用した治療を必要とする骨盤底の弱体化につながることなどが、2024年～2030年の予測期間中の世界の膣スリング市場の成長にさらに寄与しています。

したがって、上記の要因が総合的に、2024年～2030年の予測期間に膣スリング市場全体を牽引します。

しかし、術後の合併症や、失禁に関する患者集団の低い意識と偏見、厳しい承認プロセスが、膣スリング市場の成長にとっての課題となる可能性があります。

膣スリング市場は、COVID-19パンデミックの期間に影響を受けました。COVID-19パンデミックは、サプライチェーンの混乱によって生産が遅れたり、さまざまな選択手術が中止されたりしたことで、膣スリング市場に直接影響を与えるサービスが減少するなど、医療システムに影響を与えました。また、COVID-19は、外来診療予約、外来患者の検査および処置、泌尿器科手術など、世界の泌尿器科サービスの縮小に影響を与えました。さらに、さまざまな調査によると、泌尿器科サービスの削減の程度はCOVID-19パンデミックの程度とともに増加しました。平均して、外来診療の28％、外来患者の検査および処置の30％、泌尿器科手術の31％で8週間以上の遅れがありました。良性疾患向けの泌尿器科サービスは、悪性疾患向けの泌尿器科サービスよりも大きな影響を受けました。しかし、COVID-19後の選択的処置と手術の再開、製造施設の再開による病院における患者訪問の再開、膣スリングを扱うロジスティクスとサプライチェーンの再確立により、膣スリング市場の再開が見られ、予測期間の市場成長の再開につながりました。

当レポートでは、世界の膣スリング市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 膣スリング市場レポートのイントロダクション

第2章 膣スリング市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競争力の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 膣スリング市場の主な要因の分析

• 膣スリング市場の促進要因
• 膣スリング市場の抑制要因と課題
• 膣スリング市場の機会

第5章 膣スリング市場のポーターのファイブフォース分析

第6章 膣スリング市場に対するCOVID-19の影響分析

第7章 膣スリング市場情勢

• タイプ別
  • 経閉鎖孔式スリング
  • テンションフリー膣テープスリング
  • その他
• エンドユーザー別
  • 病院・診療所
  • 外来手術センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 膣スリング市場の企業と製品のプロファイル

• Cousin Surgery
• UroCure
• AMI GmbH
• Betatech Medical
• Boston Scientific Corporation
• Coloplast Corporation
• Johnson & Johnson (Ethicon)
• Promedon
• Caldera Medical Inc
• Neomedic international
• FEG Textiltechnik Forschungs
• Advin Urology.
• Dipromed Srl
• CL Medical
• Analytic Biosurgical Solution

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Vaginal Slings Market
• Table 3: Vaginal Slings Market Analysis in Global (2021-2030)
• Table 4: Vaginal Slings Market Analysis in Global by Type (2021-2030)
• Table 5: Vaginal Slings Market Analysis in Global by End-User (2021-2030)
• Table 6: Vaginal Slings Market Analysis in Global by Geography (2021-2030)
• Table 7: Vaginal Slings Market Analysis in North America (2021-2030)
• Table 8: Vaginal Slings Market Analysis in North America by Country (2021-2030)
• Table 9: Vaginal Slings Market Analysis in the US (2021-2030)
• Table 10: Vaginal Slings Market Analysis in Canada (2021-2030)
• Table 11: Vaginal Slings Market Analysis in Mexico (2021-2030)
• Table 12: Vaginal Slings Market Analysis in Europe (2021-2030)
• Table 13: Vaginal Slings Market Analysis in Europe by Country (2021-2030)
• Table 14: Vaginal Slings Market Analysis in France (2021-2030)
• Table 15: Vaginal Slings Market Analysis in Germany (2021-2030)
• Table 16: Vaginal Slings Market Analysis in the UK (2021-2030)
• Table 17: Vaginal Slings Market Analysis in Italy (2021-2030)
• Table 18: Vaginal Slings Market Analysis in Spain (2021-2030)
• Table 19: Vaginal Slings Market Analysis in the Rest of Europe (2021-2030)
• Table 20: Vaginal Slings Market Analysis in Asia-Pacific (2021-2030)
• Table 21: Vaginal Slings Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 22: Vaginal Slings Market Analysis in China (2021-2030)
• Table 23: Vaginal Slings Market Analysis in Japan (2021-2030)
• Table 24: Vaginal Slings Market Analysis in India (2021-2030)
• Table 25: Vaginal Slings Market Analysis in Australia (2021-2030)
• Table 26: Vaginal Slings Market Analysis in South Korea (2021-2030)
• Table 27: Vaginal Slings Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Table 28: Vaginal Slings Market Analysis in the Rest of the World (2021-2030)
• Table 29: Vaginal Slings Market Analysis in the Rest of the World by Region (2021-2030)
• Table 30: Vaginal Slings Market Analysis in the Middle East (2021-2030)
• Table 31: Vaginal Slings Market Analysis in Africa (2021-2030)
• Table 32: Vaginal Slings Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Vaginal Slings Market
• Figure 3: Vaginal Slings Market Analysis in Global (2021-2030)
• Figure 4: Vaginal Slings Market Analysis in Global by Type (2021-2030)
• Figure 5: Vaginal Slings Market Analysis in Global by End-User (2021-2030)
• Figure 6: Vaginal Slings Market Analysis in Global by Geography (2021-2030)
• Figure 7: Vaginal Slings Market Analysis in North America (2021-2030)
• Figure 8: Vaginal Slings Market Analysis in North America by Country (2021-2030)
• Figure 9: Vaginal Slings Market Analysis in the US (2021-2030)
• Figure 10: Vaginal Slings Market Analysis in Canada (2021-2030)
• Figure 11: Vaginal Slings Market Analysis in Mexico (2021-2030)
• Figure 12: Vaginal Slings Market Analysis in Europe (2021-2030)
• Figure 13: Vaginal Slings Market Analysis in Europe by Country (2021-2030)
• Figure 14: Vaginal Slings Market Analysis in France (2021-2030)
• Figure 15: Vaginal Slings Market Analysis in Germany (2021-2030)
• Figure 16: Vaginal Slings Market Analysis in the UK (2021-2030)
• Figure 17: Vaginal Slings Market Analysis in Italy (2021-2030)
• Figure 18: Vaginal Slings Market Analysis in Spain (2021-2030)
• Figure 19: Vaginal Slings Market Analysis in the Rest of Europe (2021-2030)
• Figure 20: Vaginal Slings Market Analysis in Asia-Pacific (2021-2030)
• Figure 21: Vaginal Slings Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 22: Vaginal Slings Market Analysis in China (2021-2030)
• Figure 23: Vaginal Slings Market Analysis in Japan (2021-2030)
• Figure 24: Vaginal Slings Market Analysis in India (2021-2030)
• Figure 25: Vaginal Slings Market Analysis in Australia (2021-2030)
• Figure 26: Vaginal Slings Market Analysis in South Korea (2021-2030)
• Figure 27: Vaginal Slings Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Figure 28: Vaginal Slings Market Analysis in the Rest of the World (2021-2030)
• Figure 29: Vaginal Slings Market Analysis in the Rest of the World by Region (2021-2030)
• Figure 30: Vaginal Slings Market Analysis in the Middle East (2021-2030)
• Figure 31: Vaginal Slings Market Analysis in Africa (2021-2030)
• Figure 32: Vaginal Slings Market Analysis in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Market Opportunities
• Figure 36: PORTER's Five Force Analysis

Vaginal Slings Market By Type (Transobturator Slings, Tension-Free Vaginal Tape Sling, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of urinary incontinence and increasing aging population prone to stress urinary incontinence and weakening of pelvic floor across the globe

The global vaginal slings market was valued at USD 1,217.99 million and is estimated to grow at a CAGR of 4.73% during the forecast period from 2024 to 2030 to reach USD 1,602.52 million by 2030. The vaginal slings market is observing significant market growth owing to key factors such as the rising prevalence of urinary incontinence cases among women, the increasing aging population prone to stress urinary incontinence and weakening of the pelvic floor, the surging development of innovative vaginal slings, and the increasing number of physical problems caused owing to conditions including pregnancy, diabetes, and menopause. Additionally, the increasing product launches & approvals, and the presence of key players in the market, among others will create a requisite for vaginal slings in the market. Lastly, the increasing healthcare expenditure will ultimately affect the demand for vaginal slings certainly. Therefore, the market of vaginal slings is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Vaginal Slings Market Dynamics:

The rising prevalence of urinary incontinence cases, especially among women is mainly driving the vaginal slings market. For instance, according to the National Association for Continence 2019, up to 40 million women in America have experienced bladder leakage issues at some point in their lives. As per the same study in 2019, almost half of new mothers experience incontinence following a normal delivery and about one in six following a cesarean section.

Additionally, as per the study mentioned by the American Academy of Family Physicians in 2019, urinary incontinence (UI) is a common issue, with a prevalence of 51% among adult women in the United States.

Moreover, as per the data provided by the Continence Foundation of Australia in 2022, over 5 million Australians - 1 in 4 people aged 15 years or over - experienced bladder or bowel control problems in the same year, and 80% of people with urinary incontinence are women. Similar trends in likely to be observed in other regions of the world. Also, it is observed that stress urinary incontinence is more common among women between the age of 41 and 55 and above.

Further, a surge in the aging population that is prone to stress urinary incontinence and weakening of the pelvic floor is expected to become a prominent driver of the vaginal slings market. For instance, according to the UN Report, World Population Ageing 2020 Highlights, globally, there were about 727 million people aged 65 years and above in 2020. Also, as per the same source, over the next three decades, the number of older people worldwide is projected to more than double, reaching approximately 1.5 billion by 2050.

Moreover, according to the United States Census Bureau 2022, more than 54 million adults above the age of 65 were living in the United States in the year 2023, accounting for about 16.5% of the United States population. As per the same source, the number of older adults living in the United States is large and growing; the total number of adults aged 65 years and older is projected to rise to an estimated 85.7 million by 2050, which accounts for about 20% of the overall population in the United States.

Thus, the increase in the aging population will lead to the development of urinary incontinence, mainly stress urinary incontinence, thereby leading to the weakening of the pelvic floor requiring treatment using stress urinary incontinence devices such as vaginal sling systems, among others are further contributing to the growth of the global vaginal slings market during the forecast period from 2024 to 2030.

Therefore, the factors stated above collectively will drive the overall vaginal slings market during the forecast period from 2024-2030.

However, postoperative complications, less awareness and stigma among the patient population regarding incontinence, and a stringent approval process may prove to be challenging factors for the vaginal slings market growth.

The vaginal slings market was impacted during the period of COVID- 19 pandemic. The COVID-19 pandemic impacted the healthcare system in several ways such as disruptions to the supply chain leading to limiting the production delay or a halt in various elective surgeries, resulting in a reduction of services directly affecting the market for vaginal slings. Also, COVID-19 impacted the cut-down of urological services globally, including outpatient clinic appointments, outpatient investigations and procedures, and urological surgeries. Further, as per various research studies, the degree of cut-down of urological services increased with the degree of the COVID-19 outbreak. On average, 28% of outpatient clinics, 30% of outpatient investigations and procedures, and 31% of urological surgeries had a delay of >8 weeks. Urological services for benign conditions were more affected than those for malignant conditions. However, with the resumption of elective procedures and surgeries post-COVID-19, the reopening of the manufacturing units resumed patient visits in the hospitals, and the re-establishment of logistics and supply chains handling the vaginal slings, there was a resumption in the vaginal slings market, thereby leading to the resumed market growth during the forecast period.

Vaginal Slings Market Segment Analysis:

Vaginal Slings Market by Type (Transobturator Slings, Tension-Free Vaginal Tape Sling, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the vaginal slings market, the tension-free vaginal tape sling segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the advantages offered by tension-free vaginal slings.

For instance, the tension-free vaginal tape sling offers faster post-operative recovery time after the surgical insertion of the vaginal sling; which is on average 2-3 weeks or less. The faster recovery time can be accounted for due to the minimally invasive surgical procedure for the insertion of the sling. The procedure involves a small vaginal incision and no abdominal incision, thereby leading to no hospital stay and a faster recovery period.

Moreover, the risk of infection, rejection, or erosion is less in a tension-free vaginal tape sling.

Additionally, other advantages such as the decreased risk of bladder injury, bowel injury, and major blood vessel injury, ease of the procedure, and efficacy, will increase the demand for the tension-free vaginal tape sling in the upcoming years.

Therefore, owing to the above-mentioned advantages, the demand for tension-free sling tape rises, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global vaginal slings market during the forecast period.

North America is expected to dominate the overall Vaginal Slings Market:

Among all the regions, North America is expected to dominate global Vaginal Slings in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the growing prevalence of stress urinary incontinence (SUI) among the population, an increase in populations susceptible to developing SUI, and the growing approval of products and others. Furthermore, research and development in the region for developing vaginal slings devices could also drive the market of vaginal slings in North America.

For instance, as per the latest data available from Urology Care Foundation 2022, around one in three women suffer from SUI at some point in their lives, and it increases with age. Over half of the women with SUI also have OAB in the US.

Further, various studies have reported that obesity and overweight are directly associated with urinary incontinence and are independent risk factors for stress-related and mixed urinary incontinence. This is because obesity increases intra-abdominal pressures, which adversely stresses the pelvic floor and can contribute to urinary stress incontinence.

Moreover, a high childbirth rate could also increase the demand for stress urinary incontinence devices among women in the country. This is because postpartum women are more prone to experience stress incontinence. According to the National Institute of Statistics and Geography, an autonomous agency of the Mexican Government, there were 1,629,211 childbirths in the country in 2020.

Thus, the increasing prevalence of urinary incontinence will increase the demand for vaginal slings as they are used to manage urinary incontinence, especially stress urinary incontinence.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the vaginal slings market.

Vaginal Slings Market Key Players:

Some of the key market players operating in the vaginal slings market include Cousin Surgery, UroCure, AMI GmbH, Betatech Medical, Boston Scientific Corporation, Coloplast Corporation, Johnson & Johnson (Ethicon), Promedon, Caldera Medical Inc., Neomedic international, FEG Textiltechnik Forschungs, Advin Urology., Dipromed Srl, CL Medical, Analytic Biosurgical Solution, and others.

Recent Developmental Activities in the Vaginal Slings Market:

In December 2022, Caldera Medical, Inc. received FDA clearance for its Desara TVez Transvaginal Sling System.

In 2019, Boston Scientific launched the AdVance XP male stress urinary incontinence sling.

Key Takeaways from the Vaginal Slings Market Report Study

Market size analysis for current vaginal slings market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vaginal slings market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global vaginal slings market.

Various opportunities available for the other competitor in the vaginal slings market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current vaginal slings market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vaginal slings market growth in the coming future?

Target Audience who can be benefited from this Vaginal Slings Market Report Study

Vaginal slings products providers

Research organizations and consulting companies

Vaginal slings-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vaginal slings

Various end users who want to know more about the vaginal slings market and the latest technological developments in the vaginal slings market.

Frequently Asked Questions for the Vaginal Slings Market:

1. What are vaginal slings?

The vaginal or urethral sling is a procedure used to manage stress urinary incontinence (SUI), which is an underdiagnosed and underreported medical problem.

2. What is the global market for vaginal slings?

The global vaginal slings market was valued at USD 1,217.99 million and is estimated to grow at a CAGR of 4.73% during the forecast period from 2024 to 2030 to reach USD 1,602.52 million by 2030.

3. What are the drivers for the global vaginal slings market?

The vaginal slings market is witnessing positive market growth owing to the factors such as the rising prevalence of urinary incontinence cases among women, the increasing aging population prone to stress urinary incontinence and weakening of the pelvic floor, the surging development of innovative vaginal slings, an increasing number of physical problems caused due to conditions including pregnancy, diabetes, and menopause, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the vaginal slings market.

4. Who are the key players operating in the global Vaginal Slings market?

Some of the key market players operating in the Vaginal Slings market include Cousin Surgery, UroCure, AMI GmbH, Betatech Medical, Boston Scientific Corporation, Coloplast Corporation, Johnson & Johnson (Ethicon), Promedon, Caldera Medical Inc., Neomedic international, FEG Textiltechnik Forschungs, Advin Urology., Dipromed Srl, CL Medical, Analytic Biosurgical Solution, and others.

5. Which region has the highest share of the vaginal slings market?

Among all the regions, North America is estimated to amass a significant revenue share in the global vaginal slings market. Some of the factors responsible for North America's vaginal slings market growth are the growing prevalence of stress urinary incontinence (SUI) among the population, an increase in populations susceptible to developing SUI, and the growing approval of products and others. Furthermore, research and development in the region for developing vaginal slings devices could also drive the market of vaginal slings in the North America.

Table of Contents

1. Vaginal Slings Market Report Introduction

2. Vaginal Slings Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Vaginal Slings Market Key Factors Analysis

• 4.1. Vaginal Slings Market Drivers
  • 4.1.1. Rising prevalence of urinary incontinence cases among women
  • 4.1.2. Increasing aging population prone to stress urinary incontinence and weakening of the pelvic floor
  • 4.1.3. Development of innovative vaginal slings
  • 4.1.4. Physical problems caused due to conditions including pregnancy, diabetes, and menopause
• 4.2. Vaginal Slings Market Restraints and Challenges
  • 4.2.1. Postoperative complications
  • 4.2.2. Less awareness and stigma among the patient population regarding incontinence
• 4.3. Vaginal Slings Market Opportunities
  • 4.3.1. Growing preference for vaginal slings that can be used in home settings
  • 4.3.2. Increasing demand for minimally-invasive surgery techniques due to patient preference

5. Vaginal Slings Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vaginal Slings Market

7. Vaginal Slings Market Layout

• 7.1. By Type
  • 7.1.1. Transobturator Slings
  • 7.1.2. Tension-free vaginal tape sling
  • 7.1.3. Others
• 7.2. By End-User
  • 7.2.1. Hospitals & Clinics
  • 7.2.2. Ambulatory Surgical Centers
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Vaginal Slings Market in USD million (2021-2030)
    • 7.3.1.2. Canada Vaginal Slings Market in USD million (2021-2030)
    • 7.3.1.3. Mexico Vaginal Slings Market in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Vaginal Slings Market in USD million (2021-2030)
    • 7.3.2.2. Germany Vaginal Slings Market in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Vaginal Slings Market in USD million (2021-2030)
    • 7.3.2.4. Italy Vaginal Slings Market in USD million (2021-2030)
    • 7.3.2.5. Spain Vaginal Slings Market in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Vaginal Slings Market in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Vaginal Slings Market in USD million (2021-2030)
    • 7.3.3.2. Japan Vaginal Slings Market in USD million (2021-2030)
    • 7.3.3.3. India Vaginal Slings Market in USD million (2021-2030)
    • 7.3.3.4. Australia Vaginal Slings Market in USD million (2021-2030)
    • 7.3.3.5. South Korea Vaginal Slings Market in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia Pacific Vaginal Slings Market in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Vaginal Slings Market in USD million (2021-2030)
    • 7.3.4.2. Africa Vaginal Slings Market in USD million (2021-2030)
    • 7.3.4.3. South America Vaginal Slings Market in USD million (2021-2030)

8. Vaginal Slings Market Company and Product Profiles

• 8.1. Cousin Surgery
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. UroCure
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. AMI GmbH
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Betatech Medical
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Boston Scientific Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Coloplast Corporation
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Johnson & Johnson (Ethicon)
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Promedon
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Caldera Medical Inc
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4 Product Listing
  • 8.9.5. Entropy
• 8.10. Neomedic international
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. FEG Textiltechnik Forschungs
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Advin Urology.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Dipromed Srl
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. CL Medical
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Analytic Biosurgical Solution
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us